Xenetic Biosciences, Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the results of the 2021 Annual Meeting of Stockholders held by Xenetic Biosciences, Inc. on December 7, 2021. The Company is incorporated in Nevada and its common stock (XBIO) and purchase warrants (XBIOW) are listed on The Nasdaq Stock Market LLC.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
Stockholders approved four key proposals at the Annual Meeting:
- Election of Directors: All seven nominees were elected. Notable vote counts included Dr. Grigory Borisenko (2,268,150 For) and Mr. Firdaus Jal Dastoor (2,839,388 For). Broker non-votes totaled 4,463,160 for this proposal.
- Ratification of Auditors: Stockholders approved the selection of Marcum LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2021 (7,554,719 For vs. 106,532 Against).
- Executive Compensation: The advisory vote on named executive officer compensation was approved (2,690,613 For vs. 472,665 Against).
- Equity Incentive Plan Amendment: Stockholders approved an amendment to increase the aggregate number of shares authorized under the Amended and Restated Equity Incentive Plan by 1,500,000 shares (2,568,737 For vs. 670,987 Against).
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, contingencies, or unusual items beyond the standard voting outcomes.
Key Facts for Investor Verification
- Verify the impact of the 1,500,000 share increase in the Equity Incentive Plan on potential future dilution.
- Review the full proxy statement for details on the specific compensation packages approved in the "Say-on-Pay" vote.
- Confirm the total number of shares outstanding and the percentage of votes represented by the significant broker non-votes (4,463,160) recorded for director elections and executive compensation.
- Check subsequent filings for the Company's financial performance for the fiscal year ending December 31, 2021, as this 8-K does not contain financial data.